These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Nonequivalence of classical MHC class I loci in ability to direct effective antiviral immunity. Pavelko KD; Mendez-Fernandez Y; Bell MP; Hansen MJ; Johnson AJ; David CS; Rodriguez M; Pease LR PLoS Pathog; 2012 Feb; 8(2):e1002541. PubMed ID: 22383876 [TBL] [Abstract][Full Text] [Related]
43. Junctional biases in the naive TCR repertoire control the CTL response to an immunodominant determinant of HSV-1. Wallace ME; Bryden M; Cose SC; Coles RM; Schumacher TN; Brooks A; Carbone FR Immunity; 2000 May; 12(5):547-56. PubMed ID: 10843387 [TBL] [Abstract][Full Text] [Related]
44. Mice transgenic for a gene that encodes a soluble, polymorphic class I MHC antigen. Hunziker R; Margulies DH Biotechnology; 1991; 16():175-85. PubMed ID: 2007189 [No Abstract] [Full Text] [Related]
45. Transplantation effects of a unique major histocompatibility complex class I mutation. Hasenkrug KJ; Stimpfling JH; Winn HJ; Nathenson SG Transplantation; 1992 Aug; 54(2):368-71. PubMed ID: 1496547 [TBL] [Abstract][Full Text] [Related]
46. Diversity and polymorphism in the MHC appear to be generated by a copy mechanism. Schulze DH; Pease LR; Yokoyama K; Geier SS; Pfaffenbach GM; Geliebter J; Zeff RA; Rosenblatt BP; Nathenson SG Transplant Proc; 1983 Dec; 15(4):2009-12. PubMed ID: 6673203 [No Abstract] [Full Text] [Related]
47. Murine antiviral proliferative and cytotoxic T-cell responses: specificities and role of the H-21 region. Kreeb G; Zinkernagel RM Transplant Proc; 1981 Mar; 13(1 Pt 2):979-81. PubMed ID: 6973868 [No Abstract] [Full Text] [Related]
48. Treatment of malignancy by direct gene transfer of a foreign MHC class I molecule. DeBruyne L Cancer Immunol Immunother; 1996 Nov; 43(3):180-9. PubMed ID: 9001572 [No Abstract] [Full Text] [Related]
49. Existence of T lymphocytes manifesting self-reactivity indistinguishable from alloreactivity: implications for self-recognition and MHC polymorphism. Altman A; Katz DH Transplant Proc; 1981 Dec; 13(4):1863-6. PubMed ID: 6977221 [No Abstract] [Full Text] [Related]
50. Adaptive value of polymorphism in intracellular self/not-self discrimination? Forsdyke DR J Theor Biol; 2001 Jun; 210(4):425-34. PubMed ID: 11403563 [TBL] [Abstract][Full Text] [Related]
51. Marijuana and host resistance to herpesvirus infection. Cabral GA; Pettit DA; Fischer-Stenger K Adv Exp Med Biol; 1993; 335():95-106. PubMed ID: 7694448 [No Abstract] [Full Text] [Related]
52. Diversity in H-2 genes encoding antigen-presenting molecules is generated by interactions between members of the major histocompatibility complex gene family. Pease LR Transplantation; 1985 Mar; 39(3):227-31. PubMed ID: 3919478 [No Abstract] [Full Text] [Related]
53. Diversity and polymorphism of the H-2 major histocompatibility complex. Transplant Proc; 1983 Dec; 15(4):2007-177. PubMed ID: 6673202 [No Abstract] [Full Text] [Related]
54. On the anomalous nature of the major histocompatibility complex in Syrian hamsters, Hm-1. Streilein JW; Duncan WR Transplant Proc; 1983 Jun; 15(2):1540-5. PubMed ID: 6603691 [No Abstract] [Full Text] [Related]
55. The concept of adaptive differentiation: relevance to MHC polymorphism, self-recognition, and leukemogenesis. Katz DH Transplant Proc; 1980 Mar; 12(1):12-5. PubMed ID: 7368283 [No Abstract] [Full Text] [Related]
56. Is allograft rejection a clue to the mechanism promoting MHC polymorphism? Andersson L; Pääbo S; Rask L Immunol Today; 1987; 8(7-8):206-9. PubMed ID: 25290428 [TBL] [Abstract][Full Text] [Related]